Rapid advances have been made in the adoption of single-use technologies over the last decade in many small-scale biopharmaceutical processes. However, it is still technically challenging to utilize ...

Intensification of upstream cell culture-based processes leads to higher cell densities and product titers, which in turn have resulted in lower process volumes and smaller, more compact processes.